Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Ibogaine in the Treatment of Opioid Addiction
2014-000354-11Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibogaine in opioid use disorder (OUD), sponsored by Radboud University Medical Center. Primary endpoints: Relapse frequency over 6 months and Subjective craving after detoxification. Started Nov 2014; status: completed.
02
Drugs
ibogaine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2014-000354-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000354-11.